These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2005-003572-38 A PHASE II, MULTI-CENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED, 2-WAY CROSS-OVER STUDY TO EVALUATE EFFICACY, PLASMA CONCENTRATIONS AND SAFETY OF 0.25ML OF 20%W/W PSD503 FOR TOPICAL APPLICATION IN FEMALE V... bad-data
Completed, but no date 2005-004652-13 Phase II, multi centre, randomised, double blind, placebo controlled, pilot study to determine efficacy, safety, tolerability and preliminary pharmacokinetics of PSD502 in the management of pain from ... bad-data
Ongoing 2005-004653-96 Phase II, single centre, randomised, double-blind, placebo-controlled study to determine the efficacy, safety and tolerability of PSD502 in the management of pain in subjects undergoing treatment for ... not-yet-due
Ongoing 2006-001334-40 A double-blind, placebo controlled study to assess the safety and preliminary efficacy of PSD506 in treatment-naïve or previously treated (washed out) patients symptoms of overactive bladder (OAB) not-yet-due
Listed as ongoing, but also has a completion date 2006-002055-32 A double-blind, placebo controlled, pilot study to assess the safety and preliminary efficacy of PSD506 in treatment-naïve or previously treated (washed out) patients with benign prostatic obstruction... 2007-11-01 bad-data
Ongoing 2006-002663-11 An open-label, escalating dose, proof of concept study to determine the effects of single oral doses of PSD506 on unstable urinary bladder contractions induced by volume provocation in subjects with d... not-yet-due
Not reported 2007-001389-34 A multi-centre, double-blind, placebo-controlled, multiple-dose crossover proof of concept study to compare the efficacy of mefenamic acid administered vaginally and orally in healthy menstruating wom... 2008-07-07 due-trials
Not reported 2007-003171-39 A phase III, multi-centre, randomized, double-blind, placebo-controlled study, with open-label follow on, to evaluate the efficacy, safety and tolerability of PDS502 in subjects with Premature Ejacula... 2009-07-16 due-trials
Not reported 2008-003650-15 A Phase II, multi-centre, double-blind, randomised, placebo-controlled, 4-way cross-over, dose-range finding study to evaluate efficacy and safety and tolerability of PSD502 in subjects with premature... 2009-07-13 due-trials